{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:19:31Z","timestamp":1792790371050,"version":"4.5.0"},"posted":{"date-parts":[[2026,9,28]]},"group-title":"Cancer Biology","reference-count":73,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"funder":[{"award":["R35GM153476"],"award-info":[{"award-number":["R35GM153476"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]},{"award":["F31CA294870"],"award-info":[{"award-number":["F31CA294870"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]},{"award":["T32GM139775"],"award-info":[{"award-number":["T32GM139775"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]},{"award":["R35CA242461"],"award-info":[{"award-number":["R35CA242461"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Sara Elizabeth O\u2019Brien Trust\/Simeon J. Fortin Charitable Foundation, Bank of America Private Bank","award":["Charles A. King Trust Postdoctoral Research Fellowship"],"award-info":[{"award-number":["Charles A. King Trust Postdoctoral Research Fellowship"]}],"id":[{"id":"https:\/\/ror.org\/006tvg625","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,9,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>CRISPR base editor (BE) scanning enables sequence-level interrogation of proteins at scale in their native cellular and genomic contexts. This approach opens new opportunities to dissect cellular pathways, where signaling depends on coordinated interactions among multiple pathway proteins. We apply BE scanning to the RAS-RAF-MEK-ERK (MAPK) cascade, a central oncogenic pathway and major therapeutic target. Compounds targeting the MAPK pathway have mechanisms of action and resistance that remain incompletely characterized. By base editing 22 MAPK genes under either hyperactivation or inhibition at various nodes, we present a chemical-genetic map of the signaling pathway. Pathway-wide analysis shows that drug resistance mutations frequently occur in proteins other than the direct drug target itself, and we exploit these chemical-genetic interactions to recapitulate key pathway connections. Our BE scanning also identified underappreciated functional hotspots, including an allosteric site in the KRAS N-terminus. We also identify catalytically impaired CRAF mutants that confer bidirectional resistance and sensitization to structurally similar MEK inhibitors, distinguishing functional differences between structurally related compounds. These findings establish BE scanning as a scalable approach for network-level chemical-genetic interaction mapping, revealing new mechanistic insights into one of the most studied oncogenic pathways.<\/jats:p>","DOI":"10.64898\/2026.09.25.753639","type":"posted-content","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:40:24Z","timestamp":1790606424000},"source":"Crossref","is-referenced-by-count":0,"title":["Pathway-wide base editing charts chemical-genetic interactions in MAPK signaling"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9171-0723","authenticated-orcid":false,"given":"James","family":"Woods","sequence":"first","affiliation":[{"name":"Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA"},{"name":"Broad Institute of Harvard and MIT, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin XiaoYang","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA"},{"name":"Broad Institute of Harvard and MIT, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Man","family":"Jang","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA"},{"name":"Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Freedman","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA"},{"name":"Broad Institute of Harvard and MIT, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Canarelli","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA"},{"name":"Broad Institute of Harvard and MIT, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Si","family":"Kwok","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA"},{"name":"Broad Institute of Harvard and MIT, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irtiza","family":"Iram","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA"},{"name":"Broad Institute of Harvard and MIT, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Eck","sequence":"additional","affiliation":[{"name":"Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA"},{"name":"Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2985-462X","authenticated-orcid":false,"given":"Brian","family":"Liau","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA"},{"name":"Broad Institute of Harvard and MIT, Cambridge, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026100107100760000_2026.09.25.753639v1.1","doi-asserted-by":"publisher","DOI":"10.1038\/nature17946"},{"key":"2026100107100760000_2026.09.25.753639v1.2","doi-asserted-by":"publisher","DOI":"10.1038\/nature24644"},{"key":"2026100107100760000_2026.09.25.753639v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.01.012"},{"key":"2026100107100760000_2026.09.25.753639v1.4","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41589-022-01167-4","article-title":"Base editor scanning charts the DNMT3A activity landscape","volume":"19","year":"2023","journal-title":"Nature Chemical Biology"},{"key":"2026100107100760000_2026.09.25.753639v1.5","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1021\/acschembio.3c00257","article-title":"Base Editor Scanning Reveals Activating Mutations of DNMT3A","volume":"18","year":"2023","journal-title":"ACS Chemical Biology"},{"key":"2026100107100760000_2026.09.25.753639v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2023.06.003"},{"key":"2026100107100760000_2026.09.25.753639v1.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2022.12.009"},{"key":"2026100107100760000_2026.09.25.753639v1.8","doi-asserted-by":"publisher","DOI":"10.1101\/2025.11.02.685764"},{"key":"2026100107100760000_2026.09.25.753639v1.9","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-024-01948-8"},{"key":"2026100107100760000_2026.09.25.753639v1.10","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cr.7290105"},{"key":"2026100107100760000_2026.09.25.753639v1.11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrclinonc.2014.83","article-title":"The clinical development of MEK inhibitors","volume":"11","year":"2014","journal-title":"Nature Reviews Clinical Oncology"},{"key":"2026100107100760000_2026.09.25.753639v1.12","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41571-022-00671-9","article-title":"The current state of the art and future trends in RAS-targeted cancer therapies","volume":"19","year":"2022","journal-title":"Nature Reviews Clinical Oncology"},{"key":"2026100107100760000_2026.09.25.753639v1.13","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1517\/17425255.2013.794220","article-title":"Clinical development of dabrafenib in BRAF mutant melanoma and other malignancies","volume":"9","year":"2013","journal-title":"Expert Opinion on Drug Metabolism & Toxicology"},{"key":"2026100107100760000_2026.09.25.753639v1.14","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.79"},{"key":"2026100107100760000_2026.09.25.753639v1.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2105281"},{"key":"2026100107100760000_2026.09.25.753639v1.16","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-13-0617"},{"key":"2026100107100760000_2026.09.25.753639v1.17","doi-asserted-by":"publisher","DOI":"10.1038\/nature08902"},{"key":"2026100107100760000_2026.09.25.753639v1.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2760-4"},{"key":"2026100107100760000_2026.09.25.753639v1.19","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.33718"},{"key":"2026100107100760000_2026.09.25.753639v1.20","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.8.8.3235"},{"key":"2026100107100760000_2026.09.25.753639v1.21","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.7.2901"},{"key":"2026100107100760000_2026.09.25.753639v1.22","doi-asserted-by":"publisher","DOI":"10.1101\/2024.10.22.618529"},{"key":"2026100107100760000_2026.09.25.753639v1.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21422-x"},{"key":"2026100107100760000_2026.09.25.753639v1.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2008.08.026"},{"key":"2026100107100760000_2026.09.25.753639v1.25","doi-asserted-by":"crossref","first-page":"110351","DOI":"10.1016\/j.celrep.2022.110351","article-title":"CRAF dimerization with ARAF regulates KRAS-driven tumor growth","volume":"38","year":"2022","journal-title":"Cell Reports"},{"key":"2026100107100760000_2026.09.25.753639v1.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.12.014"},{"key":"2026100107100760000_2026.09.25.753639v1.27","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201809138"},{"key":"2026100107100760000_2026.09.25.753639v1.28","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.celrep.2016.09.061","article-title":"Phenotypic Characterization of a Comprehensive Set of MAPK1\/ERK2 Missense Mutants","volume":"17","year":"2016","journal-title":"Cell Reports"},{"key":"2026100107100760000_2026.09.25.753639v1.29","doi-asserted-by":"publisher","DOI":"10.64898\/2026.06.12.731952"},{"key":"2026100107100760000_2026.09.25.753639v1.30","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M513068200"},{"key":"2026100107100760000_2026.09.25.753639v1.31","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.450023"},{"key":"2026100107100760000_2026.09.25.753639v1.32","doi-asserted-by":"publisher","DOI":"10.1126\/science.adp2742"},{"key":"2026100107100760000_2026.09.25.753639v1.33","doi-asserted-by":"publisher","DOI":"10.1038\/nature23291"},{"key":"2026100107100760000_2026.09.25.753639v1.34","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-2563"},{"key":"2026100107100760000_2026.09.25.753639v1.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2015.08.002"},{"key":"2026100107100760000_2026.09.25.753639v1.36","doi-asserted-by":"crossref","unstructured":"Tkacik, E. , Jang, D. M. , Boxer, K. , Ha, B. H. & Eck, M. J . Characterization and inhibitor sensitivity of ARAF, BRAF, and CRAF kinases. Journal of Biological Chemistry 301, (2025).","DOI":"10.1101\/2025.08.14.670349"},{"key":"2026100107100760000_2026.09.25.753639v1.37","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03515-1"},{"key":"2026100107100760000_2026.09.25.753639v1.38","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.2006.046300"},{"key":"2026100107100760000_2026.09.25.753639v1.39","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06123-3"},{"key":"2026100107100760000_2026.09.25.753639v1.40","doi-asserted-by":"publisher","DOI":"10.1126\/science.adg9652"},{"key":"2026100107100760000_2026.09.25.753639v1.41","unstructured":"A conserved, N-terminal tyrosine signal directs Ras for inhibition by Rabex-5 | PLOS Genetics. https:\/\/journals.plos.org\/plosgenetics\/article?id=10.1371\/journal.pgen.1008715."},{"key":"2026100107100760000_2026.09.25.753639v1.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2010.06.058"},{"key":"2026100107100760000_2026.09.25.753639v1.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2010.06.051"},{"key":"2026100107100760000_2026.09.25.753639v1.44","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw430"},{"key":"2026100107100760000_2026.09.25.753639v1.45","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9859"},{"key":"2026100107100760000_2026.09.25.753639v1.46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2107207118"},{"key":"2026100107100760000_2026.09.25.753639v1.47","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-3937"},{"key":"2026100107100760000_2026.09.25.753639v1.48","doi-asserted-by":"publisher","DOI":"10.1038\/nature12441"},{"key":"2026100107100760000_2026.09.25.753639v1.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2014.03.011"},{"key":"2026100107100760000_2026.09.25.753639v1.50","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1021\/acs.jmedchem.1c02192","article-title":"Discovery of MAP855, an Efficacious and Selective MEK1\/2 Inhibitor with an ATP-Competitive Mode of Action","volume":"65","year":"2022","journal-title":"Journal of Medicinal Chemistry"},{"key":"2026100107100760000_2026.09.25.753639v1.51","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.22.14.4984-4996.2002"},{"key":"2026100107100760000_2026.09.25.753639v1.52","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2013-4840"},{"key":"2026100107100760000_2026.09.25.753639v1.53","doi-asserted-by":"publisher","DOI":"10.1172\/JCI72763"},{"key":"2026100107100760000_2026.09.25.753639v1.54","doi-asserted-by":"publisher","DOI":"10.1038\/ng1749"},{"key":"2026100107100760000_2026.09.25.753639v1.55","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.22.21.7593-7602.2002"},{"key":"2026100107100760000_2026.09.25.753639v1.56","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-1452"},{"key":"2026100107100760000_2026.09.25.753639v1.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2021.01.008"},{"key":"2026100107100760000_2026.09.25.753639v1.58","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.celrep.2014.07.033","article-title":"RAF Suppression Synergizes with MEK Inhibition in KRAS Mutant Cancer Cells","volume":"8","year":"2014","journal-title":"Cell Reports"},{"key":"2026100107100760000_2026.09.25.753639v1.59","doi-asserted-by":"crossref","unstructured":"Dedden, D. et al. Cryo-EM Structures of CRAF2\/14-3-32 and CRAF2\/14-3-32\/MEK12 Complexes. J Mol Biol 436, 168483 (2024).","DOI":"10.1016\/j.jmb.2024.168483"},{"key":"2026100107100760000_2026.09.25.753639v1.60","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-24-0139"},{"key":"2026100107100760000_2026.09.25.753639v1.61","doi-asserted-by":"publisher","DOI":"10.64898\/2025.12.15.693503"},{"key":"2026100107100760000_2026.09.25.753639v1.62","doi-asserted-by":"publisher","DOI":"10.64898\/2026.07.24.740654"},{"key":"2026100107100760000_2026.09.25.753639v1.63","doi-asserted-by":"publisher","DOI":"10.1038\/s41589-026-02212-2"},{"key":"2026100107100760000_2026.09.25.753639v1.64","doi-asserted-by":"publisher","DOI":"10.1038\/nature10662"},{"key":"2026100107100760000_2026.09.25.753639v1.65","unstructured":"Research, C. for D. E. and. FDA grants accelerated approval to the combination of avutometinib and defactinib for KRAS-mutated recurrent low-grade serous ovarian cancer. FDA https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-accelerated-approval-combination-avutometinib-and-defactinib-kras-mutated-recurrent-low (2025)."},{"key":"2026100107100760000_2026.09.25.753639v1.66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22009-2"},{"key":"2026100107100760000_2026.09.25.753639v1.67","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2018.005"},{"key":"2026100107100760000_2026.09.25.753639v1.68","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.4169"},{"key":"2026100107100760000_2026.09.25.753639v1.69","doi-asserted-by":"publisher","DOI":"10.1002\/PRO.4792"},{"key":"2026100107100760000_2026.09.25.753639v1.70","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444910007493"},{"key":"2026100107100760000_2026.09.25.753639v1.71","doi-asserted-by":"publisher","DOI":"10.1107\/S0907444909052925"},{"key":"2026100107100760000_2026.09.25.753639v1.72","doi-asserted-by":"crossref","first-page":"8150","DOI":"10.1038\/s41467-025-63227-2","article-title":"Cryo-EM structures of CRAF\/MEK1\/14-3-3 complexes in autoinhibited and open-monomer states reveal features of RAF regulation","volume":"16","year":"2025","journal-title":"Nat Commun"},{"key":"2026100107100760000_2026.09.25.753639v1.73","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s43018-025-01081-3","article-title":"The MEK\u2013RAF molecular glue IK-595 has potent antitumor activity across RAS\/MAPK pathway-altered cancers","volume":"7","year":"2026","journal-title":"Nat Cancer"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.09.25.753639","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:22:12Z","timestamp":1790864532000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.09.25.753639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":73,"URL":"https:\/\/doi.org\/10.64898\/2026.09.25.753639","relation":{},"subject":[],"published":{"date-parts":[[2026,9,28]]},"subtype":"preprint"}}